Adriblastina 50mg injection rd 1 Vial

Product Overview

Product Form: Injection
Package Quantity: 1 Vial
Manufacturer: Pfizer
Prescription Requirement: Yes

Description

Adriblastina 50mg Injection is a chemotherapy drug containing Doxorubicin, a potent cytotoxic agent used in the treatment of various types of cancer. This medication is primarily used to manage cancers such as breast cancer, ovarian cancer, lymphoma, and leukemia. Doxorubicin works by interfering with the DNA within cancer cells, preventing them from dividing and growing. By inhibiting cancer cell replication, this drug helps control the spread of cancer in the body. Administered intravenously, Adriblastina is typically prescribed as part of a comprehensive treatment plan that may include other chemotherapy drugs and therapies.

Functions

Adriblastina 50mg Injection functions by blocking the action of an enzyme called topoisomerase II, which is essential for the replication of DNA. By disrupting the process of DNA synthesis, Doxorubicin prevents cancer cells from multiplying. This helps to stop the growth and spread of malignant tumors. It is especially effective in treating solid tumors, hematological malignancies (blood cancers), and certain types of lymphomas. The drug’s cytotoxic action makes it a crucial part of multi-drug chemotherapy regimens, enhancing the effectiveness of cancer treatment.

Precautions

Before starting treatment with Adriblastina 50mg Injection, it is important to inform your doctor about any existing medical conditions, particularly heart problems, liver disease, or a history of blood disorders. Doxorubicin can affect the heart, potentially leading to cardiac toxicity, so monitoring heart function during treatment is essential. Additionally, it should be used with caution in patients who have low blood cell counts or a compromised immune system. Since Doxorubicin can be harmful to developing fetuses, it is contraindicated during pregnancy. It is important to use effective contraception during treatment and for some time after finishing therapy. Patients should also avoid contact with people who have infections or illnesses, as chemotherapy can weaken the immune system.

Side Effects

Common side effects of Adriblastina 50mg Injection may include nausea, vomiting, hair loss, fatigue, and a decrease in blood cell counts, which can increase the risk of infection and bleeding. Other possible side effects include mouth sores, diarrhea, and skin rashes. Due to the potential for heart-related side effects, such as arrhythmias or cardiotoxicity, regular heart function monitoring is advised during treatment. In rare cases, Doxorubicin can cause severe allergic reactions, including difficulty breathing, swelling, and skin reactions. Long-term use of the drug can also lead to secondary cancers, particularly leukemia. Patients receiving Adriblastina should be monitored regularly to manage these side effects effectively.

Cautions

Adriblastina should only be administered under the supervision of a qualified healthcare provider experienced in chemotherapy treatments. Careful dosing is essential to minimize toxicity and side effects, particularly with regard to its cardiotoxic effects. The drug should not be used in patients with severe liver disease, active infections, or those with a known hypersensitivity to Doxorubicin. Patients should avoid live vaccines during treatment, as the immune system may be suppressed. If you experience any signs of allergic reactions, chest pain, or unusual fatigue, inform your healthcare provider immediately. Since chemotherapy drugs can cause severe side effects, close monitoring throughout treatment is necessary to ensure the patient’s safety and adjust dosages if needed.